洞察埃及的头癌研究:一个范围审查
Mostafa Hossam El Din Moawad1, Mahmoud Mohamed Shalaby2, Mohammed Ahmed Sadeq3
1Faculty of Pharmacy, Clinical Department, Alexandria University, Alexandria, Egypt; Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Cancer treatment and research communications
|December 12, 2023
概括
这项研究分析了2000-2022年埃及的头癌 (HNC) 研究,发现需要增加产出和合作,以改善HNC护理并与全球标准保持一致.
科学领域:
- 在瘤学瘤学.
- 医学研究 分析 分析
背景情况:
- 埃及的头癌 (HNC) 研究面临质量,数量和多样性的挑战.
- 需要加强瘤学家的参与,以满足西方医疗保健标准.
研究的目的:
- 确定埃及头癌研究的优点和缺点.
- 鼓励研究质量,数量和多样性的改善.
- 促进埃及瘤学家更大的参与.
主要方法:
- 在PubMed,Scopus,Web of Science和Embase进行了系统的文献搜索.
- 对2000年1月1日至2022年12月31日期间在埃及发表的HNC研究文章的分析.
- 在选了2150个初始记录后,包括了174篇文章.
主要成果:
- 2020年观察到的出版物数量最高,大多数文章是初级研究,主要是放射治疗的临床研究.
- 研究主要涉及成年患者,专注于服务提供,大多数发表在非埃及期刊上.
- 开罗大学是埃及作者进行研究的领先机构.
结论:
- 埃及需要更全面的HNC研究,包括病因学,危险因素和预防.
- 埃及大学的研究成果增加,多中心研究和国际合作至关重要.
- 加强研究工作将改善HNC的理解和管理,并为埃及的全球进步做出贡献.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355


